Ivan S. Coulter
Corporate Officer/Principal presso Irish Research Council
Posizioni attive di Ivan S. Coulter
Società | Posizione | Inizio | Fine |
---|---|---|---|
Irish Research Council | Corporate Officer/Principal | - | - |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Consulente / Consigliere | 01/08/2022 | - |
Storia della carriera di Ivan S. Coulter
Precedenti posizioni note di Ivan S. Coulter
Società | Posizione | Inizio | Fine |
---|---|---|---|
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Direttore degli Investimenti | 01/08/2018 | 02/12/2019 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Direttore Tecnico/Scientifico/R&S | 01/05/2018 | 02/09/2018 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Amministratore Delegato | 01/08/2003 | 02/05/2018 |
Direttore Tecnico/Scientifico/R&S | 01/08/2003 | 02/05/2018 | |
Bord Iascaigh Mhara | Direttore/Membro del Consiglio | 01/07/2007 | 02/08/2011 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | 01/01/2003 | - |
Amministratore Delegato | 01/01/2003 | 23/05/2018 | |
Fondatore | 01/01/2003 | - |
Formazione di Ivan S. Coulter
Cornell University | Masters Business Admin |
University College Dublin | Doctorate Degree |
Statistiche
Distribuzione geografica
Irlanda | 6 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Irish Research Council | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Finance |
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Commercial Services |
Bord Iascaigh Mhara |
- Borsa valori
- Insiders
- Ivan S. Coulter
- Esperienza